Hepatic and neuromuscular forms of glycogenosis type III

nine mutations in AGL.

S. Lucchiari, S. Pagliarani, S. Salani, M. Filocamo, M. Di Rocco, D. Melis, C. Rodolico, O. Musumeci, A. Toscano, N. Bresolin, G. P. Comi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Glycogenosis type III (Cori disease) is an autosomal recessive disorder caused by the deficiency of the glycogen debranching enzyme, encoded by the AGL gene, and existing in six isoforms alternately spliced in a tissue-specific way. Generally, disease onset occurs early on starting from the first year of life, with hepatomegaly, hypoglycemia, hyperlipidemia, increased CK levels, and, in some cases, short stature and slight mental retardation. Frequently, hepatomegaly tends to resolve spontaneously and inexplicably during childhood, when myopathy, often associated with cardiomyopathy, arises. This disease is known to lack almost invariably clear links between the genotype and clinical phenotype. We describe nine new mutations in Italian patients: four nonsense (p.Arg285X, p.Lys422X, p.Arg910X, p.Arg977X), three frameshift (c.442delA, c.753_756delGACA, c.3963delG), and two missense (p.Ala1120Pro, p.Arg524His). Particularly, the nonsense p.Arg285X is linked to an exonic splicing enhancer and it was found to produce two species of transcripts at the same time. Moreover, we discuss a subgroup of subjects carrying c.2681+1G>A, which has proven to be the most frequent mutation among our patients. The previously described c.664+3A>G was also detected in two patients, both homozygous. The present work is yet another confirmation that the individual genetic background plays a pivotal role in influencing the phenotypes, as occurs in other metabolic diseases.

Original languageEnglish
Pages (from-to)600-601
Number of pages2
JournalHuman Mutation
Volume27
Issue number6
Publication statusPublished - Jun 2006

Fingerprint

Glycogen Storage Disease
Glycogen Storage Disease Type III
Hepatomegaly
Mutation
Liver
Phenotype
Metabolic Diseases
Muscular Diseases
Hyperlipidemias
Cardiomyopathies
Hypoglycemia
Intellectual Disability
Protein Isoforms
Genotype
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Hepatic and neuromuscular forms of glycogenosis type III : nine mutations in AGL. / Lucchiari, S.; Pagliarani, S.; Salani, S.; Filocamo, M.; Di Rocco, M.; Melis, D.; Rodolico, C.; Musumeci, O.; Toscano, A.; Bresolin, N.; Comi, G. P.

In: Human Mutation, Vol. 27, No. 6, 06.2006, p. 600-601.

Research output: Contribution to journalArticle

Lucchiari, S, Pagliarani, S, Salani, S, Filocamo, M, Di Rocco, M, Melis, D, Rodolico, C, Musumeci, O, Toscano, A, Bresolin, N & Comi, GP 2006, 'Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL.', Human Mutation, vol. 27, no. 6, pp. 600-601.
Lucchiari, S. ; Pagliarani, S. ; Salani, S. ; Filocamo, M. ; Di Rocco, M. ; Melis, D. ; Rodolico, C. ; Musumeci, O. ; Toscano, A. ; Bresolin, N. ; Comi, G. P. / Hepatic and neuromuscular forms of glycogenosis type III : nine mutations in AGL. In: Human Mutation. 2006 ; Vol. 27, No. 6. pp. 600-601.
@article{56c58d7908174a54b72542f84087abf3,
title = "Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL.",
abstract = "Glycogenosis type III (Cori disease) is an autosomal recessive disorder caused by the deficiency of the glycogen debranching enzyme, encoded by the AGL gene, and existing in six isoforms alternately spliced in a tissue-specific way. Generally, disease onset occurs early on starting from the first year of life, with hepatomegaly, hypoglycemia, hyperlipidemia, increased CK levels, and, in some cases, short stature and slight mental retardation. Frequently, hepatomegaly tends to resolve spontaneously and inexplicably during childhood, when myopathy, often associated with cardiomyopathy, arises. This disease is known to lack almost invariably clear links between the genotype and clinical phenotype. We describe nine new mutations in Italian patients: four nonsense (p.Arg285X, p.Lys422X, p.Arg910X, p.Arg977X), three frameshift (c.442delA, c.753_756delGACA, c.3963delG), and two missense (p.Ala1120Pro, p.Arg524His). Particularly, the nonsense p.Arg285X is linked to an exonic splicing enhancer and it was found to produce two species of transcripts at the same time. Moreover, we discuss a subgroup of subjects carrying c.2681+1G>A, which has proven to be the most frequent mutation among our patients. The previously described c.664+3A>G was also detected in two patients, both homozygous. The present work is yet another confirmation that the individual genetic background plays a pivotal role in influencing the phenotypes, as occurs in other metabolic diseases.",
author = "S. Lucchiari and S. Pagliarani and S. Salani and M. Filocamo and {Di Rocco}, M. and D. Melis and C. Rodolico and O. Musumeci and A. Toscano and N. Bresolin and Comi, {G. P.}",
year = "2006",
month = "6",
language = "English",
volume = "27",
pages = "600--601",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Hepatic and neuromuscular forms of glycogenosis type III

T2 - nine mutations in AGL.

AU - Lucchiari, S.

AU - Pagliarani, S.

AU - Salani, S.

AU - Filocamo, M.

AU - Di Rocco, M.

AU - Melis, D.

AU - Rodolico, C.

AU - Musumeci, O.

AU - Toscano, A.

AU - Bresolin, N.

AU - Comi, G. P.

PY - 2006/6

Y1 - 2006/6

N2 - Glycogenosis type III (Cori disease) is an autosomal recessive disorder caused by the deficiency of the glycogen debranching enzyme, encoded by the AGL gene, and existing in six isoforms alternately spliced in a tissue-specific way. Generally, disease onset occurs early on starting from the first year of life, with hepatomegaly, hypoglycemia, hyperlipidemia, increased CK levels, and, in some cases, short stature and slight mental retardation. Frequently, hepatomegaly tends to resolve spontaneously and inexplicably during childhood, when myopathy, often associated with cardiomyopathy, arises. This disease is known to lack almost invariably clear links between the genotype and clinical phenotype. We describe nine new mutations in Italian patients: four nonsense (p.Arg285X, p.Lys422X, p.Arg910X, p.Arg977X), three frameshift (c.442delA, c.753_756delGACA, c.3963delG), and two missense (p.Ala1120Pro, p.Arg524His). Particularly, the nonsense p.Arg285X is linked to an exonic splicing enhancer and it was found to produce two species of transcripts at the same time. Moreover, we discuss a subgroup of subjects carrying c.2681+1G>A, which has proven to be the most frequent mutation among our patients. The previously described c.664+3A>G was also detected in two patients, both homozygous. The present work is yet another confirmation that the individual genetic background plays a pivotal role in influencing the phenotypes, as occurs in other metabolic diseases.

AB - Glycogenosis type III (Cori disease) is an autosomal recessive disorder caused by the deficiency of the glycogen debranching enzyme, encoded by the AGL gene, and existing in six isoforms alternately spliced in a tissue-specific way. Generally, disease onset occurs early on starting from the first year of life, with hepatomegaly, hypoglycemia, hyperlipidemia, increased CK levels, and, in some cases, short stature and slight mental retardation. Frequently, hepatomegaly tends to resolve spontaneously and inexplicably during childhood, when myopathy, often associated with cardiomyopathy, arises. This disease is known to lack almost invariably clear links between the genotype and clinical phenotype. We describe nine new mutations in Italian patients: four nonsense (p.Arg285X, p.Lys422X, p.Arg910X, p.Arg977X), three frameshift (c.442delA, c.753_756delGACA, c.3963delG), and two missense (p.Ala1120Pro, p.Arg524His). Particularly, the nonsense p.Arg285X is linked to an exonic splicing enhancer and it was found to produce two species of transcripts at the same time. Moreover, we discuss a subgroup of subjects carrying c.2681+1G>A, which has proven to be the most frequent mutation among our patients. The previously described c.664+3A>G was also detected in two patients, both homozygous. The present work is yet another confirmation that the individual genetic background plays a pivotal role in influencing the phenotypes, as occurs in other metabolic diseases.

UR - http://www.scopus.com/inward/record.url?scp=33745305424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745305424&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 600

EP - 601

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 6

ER -